Crisil ESG Ratings & Analytic Limited

Aarti Drugs Limited received an independent ESG rating of 'Crisil ESG 61 (Strong)' from Crisil ESG Ratings based on FY 2025-26 public data. The company did not engage Crisil for this rating, which was